Larry Solow's questions to West Pharmaceutical Services Inc (WST) leadership • Q2 2025
Question
In a follow-up, Larry Solow of CJS Securities asked about the drivers behind the approximate 16% underlying increase in SG&A during the quarter.
Answer
SVP & CFO Bernard Birkett responded that there were no specific, unusual items to call out. He noted that currency fluctuations, particularly the movement in the euro-to-dollar exchange rate during the quarter, had an impact on the reported SG&A figures.